• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Consumers Union calls for more stringent oversight of medtech | MassDevice.com On Call

Consumers Union calls for more stringent oversight of medtech | MassDevice.com On Call

April 23, 2013 By Arezu Sarvestani

MassDevice On Call

MASSDEVICE ON CALL — Consumer advocacy group Consumers Union submitted a letter to U.S. healthcare regulators, offering more than 11,000 signatures in favor of more stringent oversight of implantable medical devices.

CU urged the FDA to require that all high-risk medical implants undergo clinical testing vie the agency’s premarket approval process, rather than allowing them through via the less-stringent 510(k) pathway, which requires only that a device demonstrate that it’s "substantially equivalent" to a product already cleared by the FDA.

Citing the high-profile recall and subsequent lawsuits over metal-on-metal hip implants, CU asked regulators to take stronger action to prevent medical device makers from putting potentially faulty devices on the market.

"A MoM hip sold by Johnson & Johnson (NYSE:JNJ) had a 40% failure rate but the company continued to sell the remainder of their inventory, despite the knowledge of the failure rate," according to a CU press release, citing a New York Times report. "This kind of irresponsible behavior must stop. Requiring a more thorough review up front, as the current order proposes, will help to keep flawed devices from the market."

A relative newcomer, CU has made its mark on medical device lobbying. Representing the advocacy arm of Consumer Reports, CU has also has been involved in regulatory discussions involving FDA user fees and clearance status for Aptus Endosystems’ HeliFX endostapling system.

 Donating more than blood
Among the topics raised during the recent TEDMED conference included the possibility of medical contributions beyond blood donation, such as material from tumors and health data generated by self-tracking patients.
Read more

 Israeli company heeds Steve Jobs call for a better oxygen monitor
GE Healthcare (NYSE:GE) has put its support behind Israel-based Oxitone and its streamlined oxygen monitors, which CEO Dr. Leon Eisen says "solves the problem Steve Jobs was complaining about" in the hospital.
Read more

 Covidien finally closes New York plant
Medical device maker Covidien (NYSE:COV) confirmed plans to close a New York manufacturing facility, as had been foreshadowed since 2011.
Read more

Filed Under: Food & Drug Administration (FDA), News Well, Recalls Tagged With: Consumers Union, Covidien, GE Healthcare, Lobbying, On Call, Oxitone, Patient Safety

More recent news

  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot
  • Adona Medical completes enrollment in first-in-human interatrial shunt trial

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy